Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 12–12 | Cite as

Buprenorphine/naloxone cost effective for opioid abuse

Clinical study
  • 3 Downloads

References

  1. 1.
    Murphy SM, et al. Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse. Annals of Internal Medicine : 18 Dec 2018. Available from: URL: http://dx.doi.org/10.7326/M18-0227Google Scholar
  2. 2.
    Barocas JA, et al. Being Explicit About Decisions: Prescribe Medications for Opioid Use Disorder on the Basis of Proven Effectiveness, Not Beliefs. Annals of Internal Medicine : 18 Dec 2018. Available from: URL: http://dx.doi.org/10.7326/M18-3293Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations